glp 1/gip receptor agonist New strategies for the treatment of obesity and metabolic dysfunctions GLP-1 and GIP receptors signal

Objective This systematic review aims to synthesise published evidence on respiratory adverse events temporally associated with GLP-1 RA therapy in adults, characterise their patterns and severity, appraise the risk of bias using validated design-appropriate tools, describe proposed pathophysiological mechanisms, and grade the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework

Explore whether the wide health benefits of GLP1 drugssuch as blood sugar control, weight loss, heart and brain protection.

This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS

Larger randomized controlled trials with long-term follow-up are necessary to confirm these associations and evaluate the risk-benefit ratios

Gastrointestinal symptoms such as nausea, constipation, and indigestion are most common and usually subside as your body adjusts